The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Intracellular Self‐Assembly of Taxol Nanoparticles for Overcoming Multidrug Resistance
Abstract
Multidrug resistance (MDR) remains the biggest challenge in treating cancers. Herein we propose the intracellular self‐assembly of nanodrugs as a new strategy for overcoming MDR. By employing a biocompatible condensation reaction, we rationally designed a taxol derivative Ac‐Arg‐Val‐Arg‐Arg‐Cys(S t Bu)‐Lys(taxol)‐2‐cyanobenzothiazole (CBT‐Taxol) which could be subjected to furin‐controlled condensation and self‐assembly of taxol nanoparticles (Taxol‐NPs). In vitro and in vivo studies indicated that, compared with taxol, CBT‐Taxol showed a 4.5‐fold or 1.5‐fold increase in anti‐MDR effects, respectively, on taxol‐resistant HCT 116 cancer cells or tumors without being toxic to the cells or the mice. Our results demonstrate that structuring protease‐susceptible agents and assembling them intracellularly into nanodrugs could be a new optimal strategy for overcoming MDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
Cited by
Peptide–drug conjugates as effective prodrug strategies for targeted delivery
Wang, Y., Cheetham, A. G., Angacian, G., Su, H., Xie, L., & Cui, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.015 · Cited by 514
Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
Yu, W., Liu, R., Zhou, Y., & Gao, H. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01139 · Cited by 489
Designing bioresponsive nanomaterials for intracellular self-assembly
Chagri, S., Ng, D. Y. W., & Weil, T. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00373-x · Cited by 261
Metadata
- Authors
- Yuan, Y., Wang, L., Du, W., Ding, Z., Zhang, J., Han, T., An, L., Zhang, H., & Liang, G.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2015-06-26
- Volume
- 54
- Issue
- 33
- Pages
- 9700-9704
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2111190523
- Cited by
- 209
- References
- 2
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.